BSE filing, NSE: INDRAMEDCO. Summary written from the filing by ALFA Finder's alert engine.
Indraprastha Medical Corporation Ltd: key numbers
- Share price
- ₹314.20
- Market cap
- ₹2,880 Cr
- Revenue (annual)
- ₹1,483 Cr
- Net profit (annual)
- ₹183.6 Cr
- P/E (TTM)
- 15.3×Sector 51.1×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 2.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indraprastha Medical Corporation Ltd
All →Indraprastha Medical Corporation Other Announcement
The Company has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
- Value
- ₹36.67 Cr
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation Limited held its 38th AGM on September 24, 2026. Shareholders considered resolutions including a Rs. 4.00 per share dividend declaration.
Indraprastha Medical Corporation Annual Report
Indraprastha Medical Corporation Limited has released its Annual Report for FY 2025-26. The 38th Annual General Meeting is scheduled for September 24, 2026.
Indraprastha Medical Corporation Annual General Meeting
Indraprastha Medical Corporation will hold its 38th AGM on September 24, 2026. The company has fixed September 18, 2026, as the record date for dividend and e-voting.
Indraprastha Medical Corporation Q1 FY27 Results: Net Profit ₹55.9 Cr, Up 8.5% YoY
Indraprastha Medical Corporation Ltd reported revenue from operations of ₹406.1 Cr (+11.2% YoY) and net profit of ₹55.9 Cr (+8.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹55.9 Cr · +8.5% YoY
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.